Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark ...Middle East

Devdiscourse - Opinion
Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark
Drug firm Glenmark Pharmaceuticals on Monday said as per a recently published data the oral antiviral medication Favipiravir was found to provide multiple benefits in COVID-19 treatment including faster time to clinical cure. These findings were observed in a randomised, controlled Phase 3 clinical study conducted by the company and the results have been published online in the International Journal of Infectious Diseases (IJID), Glenmark said in a regulatory filing.

Hence then, the article about study shows favipiravir provides multiple benefits in covid 19 treatment glenmark was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Opinion